We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KLAR
426
Klarna Group
KLAR
$7.07B
| $239K | 0.12% |
+8,268
| New | +$284K |
|
427
Advanced Micro Devices
AMD
$741B
| $239K | 0.12% |
+1,116
| New | +$251K |
|
428
dLocal
DLO
$4.38B
| $239K | 0.12% |
16,889
-12,162
| -42% | -$172K |
|
|
HPP
429
Hudson Pacific Properties
HPP
$765M
| $238K | 0.12% |
+21,987
| New | +$326K |
|
430
Paymentus
PAY
$4.29B
| $234K | 0.12% |
+7,414
| New | +$242K |
|
431
Zumiez
ZUMZ
$347M
| $234K | 0.12% |
8,967
-6,093
| -40% | -$146K |
|
432
Sally Beauty Holdings
SBH
$1.48B
| $233K | 0.12% |
+16,363
| New | +$247K |
|
433
Sotera Health
SHC
$5.06B
| $233K | 0.12% |
+13,193
| New | +$218K |
|
434
Cameco
CCJ
$37.9B
| $233K | 0.12% |
+2,542
| New | +$229K |
|
435
LegalZoom.com
LZ
$1.39B
| $232K | 0.12% |
23,397
+11,457
| +96% | +$114K |
|
|
ALH
436
Alliance Laundry Holdings
ALH
$5.34B
| $232K | 0.12% |
+11,408
| New | +$274K |
|
|
SFD
437
Smithfield Foods
SFD
$10.7B
| $232K | 0.12% |
10,394
-4,176
| -29% | -$91.9K |
|
438
ESAB
ESAB
$5.54B
| $232K | 0.12% |
+2,075
| New | +$237K |
|
439
Duolingo
DUOL
$6.56B
| $231K | 0.12% |
+1,319
| New | +$311K |
|
440
Sanmina
SANM
$9.24B
| $231K | 0.12% |
+1,541
| New | +$227K |
|
441
Johnson Outdoors
JOUT
$500M
| $231K | 0.12% |
+5,445
| New | +$225K |
|
442
Ituran Location and Control
ITRN
$1.08B
| $231K | 0.12% |
+5,368
| New | +$211K |
|
443
First American
FAF
$8.08B
| $231K | 0.12% |
+3,755
| New | +$235K |
|
|
FINV
444
FinVolution Group
FINV
$1.16B
| $231K | 0.12% |
44,100
+12,913
| +41% | +$75.8K |
|
445
Ares Capital
ARCC
$13.7B
| $231K | 0.12% |
11,400
+1,456
| +15% | +$29.4K |
|
446
Cosan
CSAN
$3.07B
| $230K | 0.12% |
58,136
+23,985
| +70% | +$109K |
|
447
Honeywell
HON
$78.3B
| $230K | 0.12% |
1,177
-1,472
| -56% | -$288K |
|
448
iRhythm Holdings
IRTC
$3.86B
| $229K | 0.12% |
+1,292
| New | +$229K |
|
449
Cadeler
CDLR
$2.08B
| $229K | 0.12% |
+12,321
| New | +$230K |
|
450
Perdoceo Education
PRDO
$2.06B
| $229K | 0.12% |
+7,800
| New | +$246K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.